International Journal of Contemporary Pediatrics

Ramani GV et al. Int J Contemp Pediatr. 2023 Apr;10(4):535-539

http://www.ijpediatrics.com

pISSN 2349-3283 | eISSN 2349-3291

Study of tuberculosis and other infections among children (age 2 to 18 years) with multitransfused thalassemia major

Gunjan V. Ramani*, Namrata K. Makwana, Bhadresh Vyas, Mahesh Jani


Department of Pediatric, M.P. Shah Medical College, Jamanagar, Gujarat, India

Received: 14 February 2023

Revised: 10 March 2023

Accepted: 14 March 2023

*Correspondence:

Dr. Gunjan V. Ramani,

E-mail: gunjanramani97@gmail.com

Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Background: In India, beta thalassemia is prevalent across the country, with an average frequency of carriers being 3-4%. Infection is the major cause of morbidity and mortality in thalassemia, so regular screening is required for this disease.

Methods: Ethical clearance taken from institutional ethical committee. 150 thalassemia patients were enrolled in study after informed written consent. The medical histories were obtained from the patients and their files. Clinical examination was done including anthropometry, general examination, and systemic examination. MT and chest X-ray (CXR) were done for screening of tuberculosis infection. Blood samples were taken for S. ferritin, S. creatinine, serum glutamic pyruvic transaminase (SGPT), human immunodeficiency virus (HIV), and hepatitis B surface antigen (HBsAg) tests. Transfusion and other detail were taken like iron chelator, folic acid (FA) and calcium supplements.

Results: In this study, out of 150 patients, 4 patients were RVD positive and 34 patients were HCV positive. No Patients found HBsAg positive. No patient had Montoux test reactive and chest X-ray positive finding.

Conclusions: : Increase frequency of transfusion-related infection (hepatitis C, B, and HIV) in multi-transfused thalassemia. No correlation was found between tuberculosis infection and thalassemia patients in this screening study.

Keywords: Beta thalassemia, Tuberculosis, HBsAg, HCV, RVD

INTRODUCTION

Thalassemia refers to a group of genetic disorders of globin chain production in which there is an imbalance between the α-globin and β globin chain production.1 Alpha thalassemia is caused by alpha-globin gene deletion which results in reduced or absent production of alpha-globin chains. Alpha globin gene has 4 alleles and disease severity ranges from mild to severe depending on the number of deletions of the alleles. Four allele deletion is the most severe form in which no alpha globins are produced and the excess gamma chains (present during the fetal period) form tetramers. It is incompatible with life and results in hydrops fetalis. One allele deletion is the mildest form and is mostly clinically silent. Beta thalassemia results from point mutations in the beta-globin gene. It is divided into three categories based on the zygosity of the beta gene mutation. A heterozygous mutation (beta-plus thalassemia) results in beta-thalassemia minor in which beta chains are underproduced. It is mild and usually asymptomatic. Beta thalassemia major is caused by a homozygous mutation (beta-zero thalassemia) of the beta-globin gene, resulting in the total absence of beta chains. It manifests clinically as jaundice, growth retardation, hepatosplenomegaly, endocrine abnormalities, and severe anemia requiring life-long blood transfusions. The condition in between these two types is called beta-thalassemia intermedia with mild to moderate clinical symptoms.2-4

In India, β-Thalassemia is prevalent across the country, with an average frequency of carriers being 3-4%.5-7 A higher frequency has been observed in certain communities, such as Sindhis, Punjabis, Gujaratis, Bengalis, Mahars, Kolis, Saraswats, Lohanas and Gaurs.7,8 It is estimated that about 10000-15000 babies with thalassemia major (TM) are born every year.9

Infection is one of the common complications of thalassemia. There is an increased chance of tuberculosis and other infection due to abnormal immune response, blood transfusion, iron overload, splenectomy and iron chelation therapy. Due to multi transfusion they are more chances of acquiring infections like hepatitis B, C and HIV/AIDS, which is preventable. Worldwide prevalence of HBsAg -positive 0.3 to 5.7% and anti-hepatitis C antibody 4.4 to 85.4% in multi transfused thalassemia patients.

Our objectives of this study to reduce tuberculosis burdens by active detection of latent TB/active TB and to screen blood born infections (HBsAg, HCV and RVD). As a part of national tuberculosis elimination programme (NTEP) our goal to reduce TB burden in India strategically by 2025. This study aims to fulfil this goal by screening tuberculosis in cohort of thalassemia patients.

METHODS

Type of study

It was a prospective observational study.

Study duration

The duration of the study was from November 2020 to December 2022 (2 years), 1.5 years was taken for data collection, and 6 months was taken for data analysis and to derive conclusion.

Sample size

150 thalassemia patients of 2 to 18 years’ age group. This sample size derived by universal sampling method. So all patients as per inclusion criteria added.

Inclusion criteria

All thalassemia major multi-transfused children enrolled under thalassemia clinic age 2 to 18 years were included.

Exclusion criteria

Those who are already on ATT and those who will not give consent were excluded.

Methodology

Ethical approval was taken from institutional ethical committee, Shree M. P. shah medical college, Jamnagar. 150 thalassemia patients registered in thalassemia clinic were included. Demographic details of all participants were taken. History, general examination and investigation like tuberculin skin test, chest X-ray and HBsAg, HCV and RVD done. Tuberculin test was done as per NTEP guideline. 2 tuberculin unit was given intradermally in left forearm. >10 mm induration was considered for positive TST. Clinical symptoms and chest x-ray with other test result were interpreted by expert. Diagnosis and treatment of TB was done as per NTEP guideline. Those with positive TST but normal CXR and asymptomatic were considered as Latent TB. Transfusion and other detail were taken like iron chelator, FA and calcium supplements. Routine investigations like complete blood count (CBC), renal function test (RFT), and liver function test (LFT) were done.

Statistical analysis

Thus, all the data was collected and compiled in excel sheet. Appropriate test was applied for analysis wherever necessary using statistical package for the social sciences (SPSS) software.

RESULTS

In present study, a total of 150 thalassemia patients were included. A total of 77 (51.33%) male and 73 (48.66%) female was studied. Out of 150 patients, 97 patients belong to the rural area and 53 patients belongs to the urban area (Table 1). According to modified Kuppuswamy scale 76 patients belong to upper lower and 48 patient belong to lower socio economic class (Table 1).

Table 1: Socio-demographic data.
Table reproduced from source PDF page 2

A total of 150 thalassemia patients were included, the youngest being 2 years and the oldest being 18 years. 21 patients in age group 2 to 5 years, 36 patients in age group 6 to 9 years, 58 patients in age group 10 to 13 years and 35 patients in age 14 to 18 years. Maximum patients were in the age group 10-13 years (38.6%) (Figure 1).

In this study out of 150 patients 34 patients having hepatitis C infection while 4 patients having HIV infection. No patient was found HBsAg positive.

Equation reproduced from source PDF page 3

In present study prevalence of HCV infection - 22.66% and prevalence of RVD infection -2.66% (Table 2).

Thalassemia, being an autosomal recessive disorder is more common in a population where the rate of consanguinity marriage is high. In this study, consanguinity was noted in 42.6% of patients (Figure 2).

Table 2: Blood transfusion-related infection in thalassemia patient.
Table reproduced from source PDF page 3

In present study, no statistical association was found between infection and other variable like splenectomy, S. ferritin, S. creatinine, SGPT, and BT requirement (Table 3).

Table 3: Association between infection and other variable.
Table reproduced from source PDF page 3
Figure 1: Age distribution. | 21 36 58 35 Age Distribution 2-5 6-9 10-13 14-18
Figure 1: Age distribution.
Figure 2: Consangunity. | 42.6 57.3 Consangunity Yes No
Figure 2: Consangunity.

In this study, out of 150 patients 8 patients had fever, 14 patients had cough, 3 patients had headache and 1 patient had vomiting (Figure 3).

No patients have been found with latent and active tuberculosis infection (Table 4).

Table 4: LTBI comparison between two study.
Table reproduced from source PDF page 3
Figure 3: Clinical symptoms in thalassemia patient. | 0 5 10 15 Fever Cough Headache Vomiting 8 14 3 1 Symptoms
Figure 3: Clinical symptoms in thalassemia patient.

Splenectomy is indicated when thalassemia major patient has a very large spleen (>6 cm) causing physical discomfort associated with hypersplenism, an annual transfusion requirement of approximately 200 to 220 ml packed RBC/kg with a hematocrit of 70%, Greater than a 50% increase in consumption of PRBC over 6 months, clinically significant pancytopenia that persists after correction of vitamin B12 and folate deficiency. In this study out of 150 patients, 12 patients (8%) undergo splenectomy (Figure 4).

Figure 4: Splenectomy among study participants. | 8 92 Splenectomy Yes No
Figure 4: Splenectomy among study participants.

DISCUSSION

As the present study was conducted at a Government Hospital, the majority of patients enrolled are from the upper lower SE class. Out of 150 thalassemia major patient, total of 77 (51.33%) male and 73 (48.66%) female was studied. Sambhaji et al studied a total of 21 (65.6%) males and 11(34.4%) females (Table 1).10

A total of 150 thalassemia patients were included, the youngest being 2 years and the oldest being 18 years. Sambhaji et al conducted a prospective observational study in 32 multi-transfused thalassemia patients, who were >7 years of age. The youngest among them was 9 years old and the oldest was 24 years old (Figure 1).10

Thalassemia patients have multiple blood transfusions so chance of acquiring blood transfusion related infection like RVD, HBsAg and HCV is high. In present study prevalence of HCV infection - 22.66% and prevalence of RVD infection -2.66%. In a study of 196 thalassemic patients done by Mishra et al, sero prevalence of anti-HCV was high at 100 (51.1%), however anti-HIV 1/2 was 6 (3.1%) and HBsAg was 3 (1.5%) (Table 2).11

Thalassemia is an inherited (i.e. passes from parents to children through gene) blood disorder. Consanguinity is one of the risk factor for thalassemia. In this study, consanguinity was noted in 42.6% of patients. In a study of 56 thalassemic patients done by Sayed et al, consanguinity is found positive in 18 (32.1%).12 We can prevent thalassemia in consanguineous marriage by genetic counselling and avoid morbidity and mortality related to thalassemia (Figure 2).

Another study by Sriwijitalai, suggest there is common pathway via glutathione can be shown and imply the increased risk for tuberculosis among the patients with thalassemia.13 On contrary to that study, No latent or active tuberculosis in our study in thalassemia patients. There is normal CXR and MT negative in 2 visits at interval of 3 months in thalassemia patients (Table 4).

Limitations

The sample size is small and data were restricted to a single study center. For screening of tuberculosis in Thalassemia patient we had done chest X-ray and Mantoux test. Interferon gamma release assay (IGRA) test not done due to resource limitation.

CONCLUSION

This study was conducted to assess and screen tuberculosis and other infections (HBsAg, HCV and RVD) in multi transfused thalassemia patients age group 2 to 18 year. Despite increased susceptibility to infection like tuberculosis in thalassemia due to abnormal immune response, blood transfusion, iron overload, splenectomy and iron chelation therapy, no patient found tuberculosis infection. Increase frequency of transfusion related infections (hepatitis C, B and HIV) in multi transfused thalassemia. All patients should be screened for such infection regularly.

ACKNOWLEDGEMENTS

Authors would like to thank the department faculty and the patients.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: The study was approved by the Institutional Ethics Committee

REFERENCES

  1. 1. Kliegman RM, Geme JS, Blum NJ, Shah SS, Tasker RC, Wilson KM, et al. Hemoglobinopathies. In; Nelson Textbook of Pediatrics. Chapter 489. 21 Edition. 2020.
  2. 2. He LN, Chen W, Yang Y, Xie YJ, Xiong ZY, Chen DY, et al. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with βThalassemia Major: A Meta-Analysis. Biomed Res Int. 2019;6573497.
  3. 3. Vichinsky E, Cohen A, Thompson AA, Giardina PJ, Lal A, Paley C, et al. Epidemiologic and clinical characteristics of non transfusiondependent thalassemia in the United States. Pediatr Blood Cancer. 2018;65(7):e27067.
  4. 4. Ahmadpanah M, Asadi Y, Haghighi M, Ghasemibasir H, Khanlarzadeh E, Brand S. In Patients with Minor BetaThalassemia, Cognitive Performance Is Related to Length of Education, But Not to Minor Beta-Thalassemia or Hemoglobin Levels. Iran J Psychiatry. 2019;14(1):47-53.
  5. 5. Madan N, Sharma S. Sood SK, Colah R, Bhatia HM. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16-25.
  6. 6. Sinha S, Black ML, Agarwal S, Colah R, Das R, Ryan K, et al. Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counseling programmes. HUGO J. 2009;3:51-62.
  7. 7. Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other hemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4:33-42.
  8. 8. Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Physicians of India. 1996;44(1):25-8.
  9. 9. Chandy M. Developing a National Programme for India. In: Control and management of Thalassemia and other Hemoglobinopathies in the Indian Subcontinent_ Synoptic Views. Editor: Ghosh K, Colah R. Published by National institute of Immunohaematology. 2008.
  10. 10. Chate Sambhaji C. Cardiac abnormalities in patients with beta thalassemia. Int J Contemp Pediatrics. 2016;3(1):224-8.
  11. 11. Mishra K, Shah A, Patel K. Incidence of seology & molecular of HIV, HBV and HCV in thalassemia patients. Mediterranean J Hematol Infect Dis. 2020;12.
  12. 12. Sayed SZ, Aly BA, El-Hakim A, Omar SM, Amin AS. The early cardiac involvement in patients with B-thalassemia major. Egyptian Heart J. 2013;65:243-9.
  13. 13. Sriwijitalai W, Wiwanitkit V. Tuberculosis in patient with underlying thalassemia: a consideration of common antioxidative pathway- an expressional analysis. Egypt J Chest Dis Tuberculosis. 2021;70(1):38-9.